Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898313 · ClinicalTrials.gov registry record
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Recruiting
- Registry status
- 4,000
- Enrollment target
NCT00898313: Recruiting study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00898313 is a clinical trial that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 4,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898313 is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
Primary Outcome
As a part of the study nasal brushing specimens, sputum, blood, urine, and a small amount of other tissue will be collected during standard of care procedures (bronchial epithelial, trans-thoracic fine needle aspiration (FNA) and thoracentesis as part of patient work up. Clinical diagnosis is the primary goal of the procedure. All the research specimens are collected after the primary goal of the procedure is met.
Interventions
- OTHER biologic sample preservation procedure
- GENETIC comparative genomic hybridization
- GENETIC gene expression microarray analysis
- GENETIC proteomic profiling analysis
- PROCEDURE nasal brushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2003-12 |
| Est. Completion | 2027-01-31 |
What NCT00898313 shows while recruiting
NCT00898313 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which biologic sample preservation procedure is the first listed.
NCT00898313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898313 about?
NCT00898313 is a clinical study titled "Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer". RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of...
What is the current status of trial NCT00898313?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2003-12. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT00898313?
The interventions under investigation include: biologic sample preservation procedure (OTHER), comparative genomic hybridization (GENETIC), gene expression microarray analysis (GENETIC), proteomic profiling analysis (GENETIC), nasal brushing (PROCEDURE).
Who is sponsoring clinical trial NCT00898313?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia